# Neos Therapeutics, Inc. (NEOS)

Source: https://www.quantisnow.com/company/NEOS
Generated: 2026-11-06T00:10:54.275Z

- Ticker: NEOS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Major Pharmaceuticals
- IPO year: 2015

## Latest NEOS news and filings

- 2023-10-16 08:40 UTC [FDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INC](https://www.quantisnow.com/insight/fda-approval-for-cotempla-xr-odt-issued-to-neos-theraps-inc-5020331)
- 2021-06-28 09:08 UTC [FDA Approval for COTEMPLA XR-ODT issued to NEOS THERAPS INC](https://www.quantisnow.com/insight/fda-approval-for-cotempla-xr-odt-issued-to-neos-theraps-inc-1162154)
- 2021-03-26 04:15 UTC [SEC Form EFFECT filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-neos-therapeutics-inc-555550)
- 2021-03-26 04:15 UTC [SEC Form EFFECT filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-neos-therapeutics-inc-555519)
- 2021-03-26 04:15 UTC [SEC Form EFFECT filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-neos-therapeutics-inc-555506)
- 2021-03-26 04:15 UTC [SEC Form EFFECT filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-neos-therapeutics-inc-555496)
- 2021-03-22 10:11 UTC [SEC Form 8-K] [SEC Form 8-K filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-neos-therapeutics-inc-533970)
- 2021-03-22 10:09 UTC [SEC Form 425] [SEC Form 425 filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-neos-therapeutics-inc-533961)
- 2021-03-19 22:26 UTC [SEC Form 4] [SEC Form 4: M John Limongelli disposed to the issuer $0 worth of Common Stock (83,015 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-m-john-limongelli-disposed-to-the-issuer-532738)
- 2021-03-19 21:36 UTC [SEC Form 4] [SEC Form 4: Jr. A. James Robinson disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-jr-a-james-robinson-disposed-to-the-532643)
- 2021-03-19 21:35 UTC [SEC Form 4] [SEC Form 4: W. Gerald Mclaughlin disposed to the issuer $0 worth of Common Stock (270,171 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-w-gerald-mclaughlin-disposed-to-the-issuer-532641)
- 2021-03-19 21:34 UTC [SEC Form 4] [SEC Form 4: Beth Hecht disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-beth-hecht-disposed-to-the-issuer-0-532638)
- 2021-03-19 21:33 UTC [SEC Form 4] [SEC Form 4: P. John Schmid disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-p-john-schmid-disposed-to-the-issuer-532635)
- 2021-03-19 21:32 UTC [SEC Form 4] [SEC Form 4: Bryant Fong disposed to the issuer $0 worth of Common Stock (24,953 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-bryant-fong-disposed-to-the-issuer-0-532631)
- 2021-03-19 21:31 UTC [SEC Form 4] [SEC Form 4: M Linda Szyper disposed to the issuer $0 worth of Common Stock (23,453 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-m-linda-szyper-disposed-to-the-issuer-532626)
- 2021-03-19 21:23 UTC [SEC Form 4] [SEC Form 4: J Gregory Robitaille disposed to the issuer $0 worth of Common Stock (79,130 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-j-gregory-robitaille-disposed-to-the-issuer-532574)
- 2021-03-19 21:05 UTC [SEC Form 4] [SEC Form 4: L Alan Heller disposed to the issuer $0 worth of Common Stock (446,819 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-l-alan-heller-disposed-to-the-issuer-532460)
- 2021-03-19 21:04 UTC [SEC Form 4] [SEC Form 4: I Richard Eisenstadt disposed to the issuer $0 worth of Common Stock (126,245 units at $0.00), decreasing direct ownership by 100% to 0 units](https://www.quantisnow.com/insight/sec-form-4-i-richard-eisenstadt-disposed-to-the-issuer-532446)
- 2021-03-19 20:53 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532359)
- 2021-03-19 20:51 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532345)
- 2021-03-19 20:49 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532335)
- 2021-03-19 20:48 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532327)
- 2021-03-19 20:46 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532320)
- 2021-03-19 20:43 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532306)
- 2021-03-19 20:40 UTC [SEC Form S-8 POS filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-neos-therapeutics-inc-532298)
- 2021-03-19 20:37 UTC [SEC Form POS AM filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-neos-therapeutics-inc-532277)
- 2021-03-19 20:36 UTC [SEC Form POS AM filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-neos-therapeutics-inc-532270)
- 2021-03-19 20:34 UTC [SEC Form POS AM filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-neos-therapeutics-inc-532260)
- 2021-03-19 20:32 UTC [SEC Form POS AM filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-neos-therapeutics-inc-532232)
- 2021-03-19 20:19 UTC [SEC Form 25-NSE filed by Neos Therapeutics, Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-neos-therapeutics-inc-532086)
- 2021-03-16 12:51 UTC [SEC Form 4] [SEC Form 4: W. Gerald Mclaughlin disposed of $37,414 worth of Common Stock (44,329 units at $0.84), decreasing direct ownership by 14% to 270,171 units](https://www.quantisnow.com/insight/sec-form-4-w-gerald-mclaughlin-disposed-of-37414-worth-515347)
- 2021-03-16 12:49 UTC [SEC Form 4] [SEC Form 4: M John Limongelli disposed of $14,335 worth of Common Stock (16,985 units at $0.84), decreasing direct ownership by 17% to 83,015 units](https://www.quantisnow.com/insight/sec-form-4-m-john-limongelli-disposed-of-14335-worth-515336)
- 2021-03-16 12:49 UTC [SEC Form 4] [SEC Form 4: I Richard Eisenstadt disposed of $13,740 worth of Common Stock (16,215 units at $0.85), decreasing direct ownership by 11% to 126,245 units](https://www.quantisnow.com/insight/sec-form-4-i-richard-eisenstadt-disposed-of-13740-worth-515330)
- 2021-03-12 16:27 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-505980)
- 2021-03-12 14:04 UTC [Conference Announcement] [Glass Lewis, a Leading Independent Proxy Advisory Firm, Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience](https://www.quantisnow.com/insight/glass-lewis-a-leading-independent-proxy-advisory-firm-recommends-neos-505471)
- 2021-03-10 21:40 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-496611)
- 2021-03-10 21:01 UTC [Leading Independent Proxy Advisory Firm ISS Recommends Neos Therapeutics Stockholders Vote “FOR” the Pending Merger With Aytu BioScience](https://www.quantisnow.com/insight/leading-independent-proxy-advisory-firm-iss-recommends-neos-therapeutics-stockholders-495945)
- 2021-02-23 21:10 UTC [Public Offering] [Hercules Capital Reports Fourth Quarter and Full-Year 2020 Financial Results](https://www.quantisnow.com/insight/hercules-capital-reports-fourth-quarter-and-full-year-2020-financial-results-423768)
- 2021-02-16 13:52 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-397482)
- 2021-02-12 22:07 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-392370)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NEOS
- Earnings history: https://www.quantisnow.com/earnings/NEOS
- Dividend history: https://www.quantisnow.com/dividends/NEOS
- Insider transactions: https://www.quantisnow.com/insiders/NEOS
- Options chain: https://www.quantisnow.com/options/NEOS
- SEC 8-K filings only: https://www.quantisnow.com/company/NEOS/8-k
- RSS and alerts for NEOS: https://www.quantisnow.com/docs/rss-feeds.md